To The Moon

May Lim Introduction It's time to talk about one of the two stocks in my portfolio with a sub-1% dividend yield: Danaher Corporation . This healthcare-focused corporation is currently my 8th-largest investment after I aggressively added to it during this year's various sell-offs. My most recent article, titled Danager Sells Off - I'm Buying, was written in April when the stock sold off more than 6% after earnings. Since then, the stock has risen 14%, as just-released earnings have caused the stock to break out from the downtrend that started in 2021. FINVIZ This downtrend was fueled by rising rates and evaporating COVID benefits. While both of these headwinds are still an issue, they are quickly fading, allowing investors to focus on the company's core business again, which continues to fare extremely well. In this article, I'll cover these numbers and explain why I'm a buyer on any corrections down the road. So, let's get to it!

One analyst expects the growth in earnings to be “less significant” than last year due to growing funding and operating costs.